Form 4: Nuvation Bio Inc. Director Sells Shares to Cover Tax Obligations

A Nuvation Bio Inc. director, Junyuan Jerry Wang, sold 56,361 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Junyuan Jerry Wang, a director and officer of Nuvation Bio Inc., sold 56,361 shares of Class A Common Stock on November 11, 2024.
• The shares were sold at a price of $2.89 per share.
• The sale was to cover tax withholding obligations associated with the vesting of performance-based restricted stock units.
• Following the transaction, Wang directly owns 3,866,228 shares and indirectly owns 2,246,458 shares through WangWang, LLC.
• The sale was not a discretionary transaction but rather a 'sell to cover' to meet tax obligations.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing regarding an insider stock sale for tax purposes, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine filing related to insider transactions, which are common in publicly traded companies. It reflects a director selling shares to cover tax obligations, a typical practice.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The sale of shares to cover tax obligations is a common occurrence among executives and directors who receive equity compensation.
• The transaction is similar to those of other executives in comparable biotech companies who receive stock-based compensation.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on the stock price, but it is not expected to be significant as it is a routine transaction for tax purposes.

Key Dates

Keywords

Nuvation Bio Inc., insider trading, Form 4, stock sale, Junyuan Jerry Wang, tax obligations, restricted stock units, Class A Common Stock